40 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
could result, including:
we may be forced to recall such product and suspend the marketing of such product;
regulatory authorities may withdraw … and the general public have raised concerns about potential drug safety issues. These events have resulted in the recall and withdrawal of drug products
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
consequences could result, including:
we may be forced to recall such product and suspend the marketing of such product;
regulatory authorities may … professionals and the general public have raised concerns about potential drug safety issues. These events have resulted in the recall and withdrawal of drug
424B5
SLNO
Soleno Therapeutics Inc
30 Mar 22
Prospectus supplement for primary offering
5:21pm
to recall such product and suspend the marketing of such product;
regulatory authorities may withdraw their approvals of such product;
regulatory … in the recall and withdrawal of drug products, revisions to drug labeling that further limit use of the drug products and establishment of risk management
424B5
wh0gc
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
ro1pa ijmcgf
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
424B5
4vmr e8ut6ngjceesb
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
lkg9pmbg1u ee2g4e3y
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
m44klrhyaan70 wbz
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
c1wxc7d
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
pgrq cduyp1v5dozz57k
12 Apr 19
Prospectus supplement
4:41pm